Amj Financial Wealth Management / TMO
Amj Financial Wealth Management’s Thermo Fisher Scientific Inc Position
Does Amj Financial Wealth Management own Thermo Fisher Scientific Inc (TMO)? Not currently — the last reported position was 14.9K shares worth $9M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$9M
Q4 2025
Shares
14.9K
% of Portfolio
+2.05%
Quarters Held
15
position exited
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 14.9K | $9M | +2.05% |
| Q1 2023 | 5.0K | $3M | +1.85% |
| Q4 2022 | 4.9K | $3M | +1.60% |
| Q3 2022 | 8.4K | $4M | +2.75% |
| Q2 2022 | 9.0K | $5M | +4.15% |
| Q1 2022 | 9.0K | $5M | +2.13% |
| Q4 2021 | 11.6K | $8M | +2.80% |
| Q3 2021 | 7.6K | $4M | +1.78% |
| Q2 2021 | 4.6K | $2M | +1.01% |
| Q1 2021 | 12.0K | $5M | +2.65% |
| Q4 2020 | 11.6K | $5M | +2.75% |
| Q3 2020 | 11.6K | $5M | +3.02% |
| Q2 2020 | 11.8K | $4M | +2.91% |
| Q1 2020 | 4.3K | $1M | +2.12% |
| Q4 2019 | 12.1K | $4M | +2.76% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amj Financial Wealth Management’s full portfolio or all institutional holders of TMO.